Kura Oncology, Inc.
Develops targeted precision medicines for high-need cancers like leukemia, head & neck, and lung cancer.
KURA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US50127T1097
- LEI:
- Country:
- United States of America
- Address:
- 4930 DIRECTORS PLACE, SUITE 500, 92121 SAN DIEGO
- Website:
- https://www.kuraoncology.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for cancer. The company discovers and develops novel, targeted therapeutics by leveraging a deep understanding of the molecular processes that drive the disease. Its development pipeline focuses on addressing high unmet medical needs in cancers such as acute leukemias, head and neck cancer, and lung cancer. Kura aims to provide patients with innovative treatments, including small molecule drug candidates, designed to achieve durable remissions and improve outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all Kura Oncology, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kura Oncology, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kura Oncology, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
